Normalized Pre-Tax Income: A company's income before income tax expense smoothed out by removing non-recurring items.
OKYO Pharma Limited Sponsored ADR (OKYO) had Normalized Pre-Tax Income of $-8.94M for the most recently reported fiscal year, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-8.95M |
|
-- |
|
-- |
|
$8.50M |
|
$-8.50M |
|
$-0.44M |
|
$-8.94M |
|
|
Normalized Pre-Tax Income |
$-8.94M |
$-8.95M |
|
$-8.95M |
|
$-8.95M |
|
$-8.95M |
|
$-8.50M |
|
$-8.50M |
|
37.36M |
|
37.36M |
|
$-0.24 |
|
$-0.24 |
|
| Balance Sheet Financials | |
$20.97M |
|
$0.01M |
|
$0.01M |
|
$20.98M |
|
$8.64M |
|
-- |
|
-- |
|
$8.64M |
|
$12.34M |
|
$12.34M |
|
$12.34M |
|
52.48M |
|
| Cash Flow Statement Financials | |
$-5.94M |
|
$-6.01M |
|
$25.02M |
|
$1.56M |
|
$14.59M |
|
$13.03M |
|
$1.61M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.43 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-5.94M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-72.55% |
|
-72.55% |
|
-42.67% |
|
-72.55% |
|
$0.23 |
|
$-0.16 |
|
$-0.16 |
|